Muscle strength and motor function throughout life in a cross‐sectional cohort of 180 patients with spinal muscular atrophy types 1c–4
European Journal of Neurology2017Vol. 25(3), pp. 512–518
Citations Over TimeTop 10% of 2017 papers
Renske I. Wadman, Camiel A. Wijngaarde, Marloes Stam, Bart Bartels, Louise Otto, Henny H. Lemmink, Marja Schoenmakers, Inge Cuppen, L. van den Berg, W. Ludo van der Pol
Abstract
Progressive muscle weakness and loss of motor function are characteristic of all SMA types and all ages.
Related Papers
- → The First Orally Deliverable Small Molecule for the Treatment of Spinal Muscular Atrophy(2020)88 cited
- → Rehabilitation Training Activity Analysis Method for Motor Function in Lower Limb in Elderly Patients with Hemiplegia after Stroke(2020)1 cited
- → Recent Progress in Gene-Targeting Therapies for Spinal Muscular Atrophy: Promises and Challenges(2024)5 cited
- [Spinal muscular atrophy treated with nusinersen].(2019)
- → [Research progress on biomarkers for the monitoring of Spinal muscular atrophy].(2024)